Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VEGF and HTRA1 DNA Polymorphisms in Neovascular AMD Pathogenesis and Response to Lucentis

NCT00474695 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT00474695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00474695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VEGF and HTRA1 DNA Polymorphisms in Neovascular AMD Pathogenesis and Response to Lucentis
Lead sponsor
University of Utah
Phase
Observational
Overall status
Terminated
Start date
May 31, 2007
Completion date
December 31, 2009
Enrollment
65 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

age-related maculopathy